BEIJING & CAMBRIDGE, Mass.–EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery, today announced the successful completion of approximately $15 Million in a Series pre-B financing. The financing is led by new investor Lilly Asia Ventures (LAV). New investor Huagai […]
MINNEAPOLIS — Bio-Techne has introduced a new range of Tocris Bioscience-branded stem cell research compounds produced to cGMP standards, which are suitable for use as ancillary materials in the development of stem cell therapies. Bio-Techne has a highly-qualified team who have full control over the cGMP process, meaning we can ensure: a quality assured manufacturing system, […]
AUSTIN, TEXAS — The Intelligence Advanced Research Projects Activity (IARPA) awarded Signature Science, LLC, a $2.3M contract for the development of the Proteo-ID method. Proteo-ID aims to accurately identify people via protein sequencing from human skin cell samples. The Proteo-ID methodology will significantly expand human forensic analysis through the sequencing of proteins, which are stable […]
By using nanotechnology, Nicoya’s OpenSPR instrument allows scientists to better understand diseases and develop new drugs to treat them. With over 500 users in more than 25 different countries, the company continues helping scientists solve their toughest research challenges in both industry and academia. Nicoya’s new two-channel OpenSPR KITCHENER, CANADA Since their establishment in 2012, […]
Genomic Vision grants European Equity Partner (EEP) a license to its proprietary technology. During the evaluation period, the parties will confirm interest of molecular combing as a genome integrity assay as a quality control tool in biomanufacturing of proteins This strategic collaboration is aimed at building a Bioanalytical Services Company offering specific leading analytical services […]
Oxford – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound contract with a leading multi-billion dollar global ecommerce provider of reagents and tools to the research and clinical community. As part of the agreement, Oxford Genetics will leverage its high throughput automated genomic engineering […]
Two Leading Centers to Explore Spatial Genomics Synergies with Single-Cell Biology, Next-Generation Sequencing, and Advanced Imaging Technologies Announces Early Access Launch for Five Additional Beta Instruments SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company has added two new Centers of Excellence […]
Powerful, flexible and easy-to-use analysis solution gets the most out of NGS data Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of the eagerly-anticipated update to its SureSeq™ Interpret software, included with purchases of SureSeq NGS panels. Designed to help researchers effortlessly translate cumbersome NGS data into meaningful results, OGT has […]
SAN DIEGO – Maravai LifeSciences, a leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, announced today that it has completed a new debt financing that was enabled by the company’s strong historical financial performance. In addition to refinancing Maravai’s existing debt at a lower interest rate, the new issuance also provides […]
Includes growth equity investment from Ampersand Capital Partners MEMPHIS, TN and BOTHEL, WA – Key Biologics, has completed its merger with Astarte Biologics to create the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry. In conjunction with the merger the new entity also received an investment from Ampersand […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
